According to the pharmaceutical company data, people between 18 and 55 years old with a third dose of their coronavirus vaccine would have five times more antibodies and older adults could have up to 11 times more antibodies. July 28, 2021
Pfizer Says A Third Dose Of Its Vaccine Would Increase Antibodies Against The Delta Variant
2021-07-28T18:20:22.355Z
According to the pharmaceutical company data, people between 18 and 55 years old with a third dose of their coronavirus vaccine would have five times more antibodies and older adults could have up to 11 times more antibodies.